SCHEMBL7047895

SCHEMBL7047895

O=C(c1ccccc1)c1cc(O)c(O)c([N+](=O)[O-])c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 8/20 0.73
GPR35 Q9HC97 3/20 0.73
COMT P21964 2/20 0.73
ABCC3 O15438 1/20 0.73
ABCC4 O15439 1/20 0.73
NR1I2 O75469 1/20 0.73
ABCB11 O95342 1/20 0.73
NR3C1 P04150 1/20 0.73
PGR P06401 1/20 0.73
HTR1A P08908 1/20 0.73
ADORA3 P0DMS8 1/20 0.73
RARB P10826 1/20 0.73
SLC6A2 P23975 1/20 0.73
ADORA1 P30542 1/20 0.73
ADRA1A P35348 1/20 0.73
PTGS2 P35354 1/20 0.73
SLC6A3 Q01959 1/20 0.73
KCNH2 Q12809 1/20 0.73
KLF10 Q13118 1/20 0.73
PDE3A Q14432 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7368380 0.90 TTR (0.81) TTRGPR35COMTABCC3ABCC4
Bromide SCHEMBL7365276 0.88 TTR (0.78) TTRGPR35COMTABCC3ABCC4
SCHEMBL7363677 0.87 TTR (0.78) TTRGPR35COMTABCC3ABCC4
SCHEMBL6725029 0.84 VCAM1 (0.56) TTRGPR35COMTABCC3ABCC4
SCHEMBL7365493 0.84 TTR (0.69) TTRGPR35COMTABCC3ABCC4
Tolcapone SCHEMBL29360457 0.84 TTR (1.00) TTRGPR35COMTABCC3ABCC4
SCHEMBL8466506 0.84 TTR (0.78) TTRGPR35COMTABCC3ABCC4
Tolcapone SCHEMBL33869 0.84 TTR (1.00) TTRGPR35COMTABCC3ABCC4
Tolcapone SCHEMBL5496772 0.84 TTR (1.00) TTRGPR35COMTABCC3ABCC4
SCHEMBL10823867 0.84 TTR (0.61) TTRGPR35COMTABCC3ABCC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5476875-A Catechol derivatives HOFFMAN-LA ROCHE INC. (US) 1995-12-19 US claimed
US-5236952-A Inhibit the enzyme catechol-O-methyltransferase; for treatment of Parkinson's disease administered with L-dopa HOFFMANN-LA ROCHE INC. (US) 1993-08-17 US claimed
EP-0237929-A1 3,5-Disubstituted pyrocatechol derivatives F. HOFFMANN-LA ROCHE AG (CH) 1987-09-23 EP claimed
EP-1010688-B1 Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them PORTELA & CA SA (PT) 2003-04-09 EP disclosed
US-6512136-B1 Hypotensive, antiedemic agents; gastrointestinal disorders; Parkinson*s disease treatment PORTELA & C.A., S.A. (PT) 2003-01-28 US disclosed
EP-1010688-A1 Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them Portela & Ca., S.A. (PT) 2000-06-21 EP disclosed
US-5877353-A Process for the preparation of benzophenone derivatives HOFFMANN-LA ROCHE INC. (US) 1999-03-02 US disclosed
US-5705703-A ENZYME INHIBITORS OF TRANSFERASES HOFFMANN-LA ROCHE INC. (US) 1998-01-06 US disclosed
US-5633371-A ENZYME INHIBITORS; TREATMENT OF DEPRESSION AND PARKINSON*S DISEASE HOFFMANN-LA ROCHE INC. (US) 1997-05-27 US disclosed
US-5476875-A Catechol derivatives HOFFMAN-LA ROCHE INC. (US) 1995-12-19 US disclosed
US-5389653-A Inhibitors of the enzyme catechol-O-methyltransferase; useful as co-medication in treatment of Parkinson's disease HOFFMAN-LA ROCHE INC. (US) 1995-02-14 US disclosed
US-5236952-A Inhibit the enzyme catechol-O-methyltransferase; for treatment of Parkinson's disease administered with L-dopa HOFFMANN-LA ROCHE INC. (US) 1993-08-17 US disclosed
EP-0237929-B1 3,5-DISUBSTITUTED PYROCATECHOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1993-06-02 EP disclosed
EP-0237929-A1 3,5-Disubstituted pyrocatechol derivatives F. HOFFMANN-LA ROCHE AG (CH) 1987-09-23 EP disclosed